{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:27:59Z","timestamp":1794065279404,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2020\/133\/Startup\/08"],"award-info":[{"award-number":["NUHSRO\/2020\/133\/Startup\/08"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41563-025-02284-w","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T09:03:55Z","timestamp":1754039035000},"page":"1826-1839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation"],"prefix":"10.1038","volume":"24","author":[{"given":"Yunxuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-8993","authenticated-orcid":false,"given":"Wanbo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4261-7657","authenticated-orcid":false,"given":"Miya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-8287","authenticated-orcid":false,"given":"Fangfang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-5488","authenticated-orcid":false,"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-0870","authenticated-orcid":false,"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-4184","authenticated-orcid":false,"given":"Guocan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2284_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N. et al. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2284_CR2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X. et al. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"2284_CR3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","volume":"23","author":"N Pardi","year":"2024","unstructured":"Pardi, N. & Krammer, F. mRNA vaccines for infectious diseases\u2014advances, challenges and opportunities. Nat. Rev. Drug. Discov. 23, 838\u2013861 (2024).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"2284_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","volume":"23","author":"Y Ju","year":"2023","unstructured":"Ju, Y. et al. Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines. Nat. Rev. Immunol. 23, 135\u2013136 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2284_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","volume":"24","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Current developments and challenges of mRNA vaccines. Annu. Rev. Biomed. Eng. 24, 85\u2013109 (2022).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"2284_CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","volume":"403","author":"JS Weber","year":"2024","unstructured":"Weber, J. S. et al. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study. Lancet 403, 632\u2013644 (2024).","journal-title":"Lancet"},{"key":"2284_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","volume":"24","author":"S Ndeupen","year":"2021","unstructured":"Ndeupen, S. et al. The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience 24, 103479 (2021).","journal-title":"iScience"},{"key":"2284_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biomedicines12010059","volume":"12","author":"I Pateev","year":"2023","unstructured":"Pateev, I. et al. Biodistribution of RNA vaccines and of their products: evidence from human and animal studies. Biomedicines 12, 59 (2023).","journal-title":"Biomedicines"},{"key":"2284_CR9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","volume":"25","author":"K Bahl","year":"2017","unstructured":"Bahl, K. et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther. 25, 1316\u20131327 (2017).","journal-title":"Mol. Ther."},{"key":"2284_CR10","volume":"120","author":"Z Ye","year":"2023","unstructured":"Ye, Z. et al. Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants. Proc. Natl Acad. Sci. USA 120, e2311752120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2284_CR11","doi-asserted-by":"crossref","first-page":"eabo1827","DOI":"10.1126\/sciadv.abo1827","volume":"8","author":"Y Shi","year":"2022","unstructured":"Shi, Y. et al. Structural and biochemical characteristics of mRNA nanoparticles determine anti-SARS-CoV-2 humoral and cellular immune responses. Sci. Adv. 8, eabo1827 (2022).","journal-title":"Sci. Adv."},{"key":"2284_CR12","volume":"119","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response. Proc. Natl Acad. Sci. USA 119, e2207841119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2284_CR13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jiac.2021.12.034","volume":"28","author":"H Kitagawa","year":"2022","unstructured":"Kitagawa, H. et al. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan. J. Infect. Chemother. 28, 576\u2013581 (2022).","journal-title":"J. Infect. Chemother."},{"key":"2284_CR14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5501\/wjv.v12.i2.100","volume":"12","author":"G Schinas","year":"2023","unstructured":"Schinas, G. et al. Immune-mediated liver injury following COVID-19 vaccination. World J. Virol. 12, 100\u2013108 (2023).","journal-title":"World J. Virol."},{"key":"2284_CR15","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.32572","volume":"76","author":"C Efe","year":"2022","unstructured":"Efe, C. et al. Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76, 1576\u20131586 (2022).","journal-title":"Hepatology"},{"key":"2284_CR16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","volume":"77","author":"T Boettler","year":"2022","unstructured":"Boettler, T. et al. SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis. J. Hepatol. 77, 653\u2013659 (2022).","journal-title":"J. Hepatol."},{"key":"2284_CR17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2021.09.031","volume":"76","author":"GS Zin Tun","year":"2022","unstructured":"Zin Tun, G. S. et al. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. J. Hepatol. 76, 738\u2013753 (2022).","journal-title":"J. Hepatol."},{"key":"2284_CR18","doi-asserted-by":"crossref","first-page":"114990","DOI":"10.1016\/j.addr.2023.114990","volume":"200","author":"M Jeong","year":"2023","unstructured":"Jeong, M. et al. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Adv. Drug Deliv. Rev. 200, 114990 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2284_CR19","doi-asserted-by":"crossref","first-page":"eadk2444","DOI":"10.1126\/sciadv.adk2444","volume":"10","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy. Sci. Adv. 10, eadk2444 (2024).","journal-title":"Sci. Adv."},{"key":"2284_CR20","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/pharmaceutics14081572","volume":"14","author":"K Sasaki","year":"2022","unstructured":"Sasaki, K. et al. mRNA-loaded lipid nanoparticles targeting dendritic cells for cancer immunotherapy. Pharmaceutics 14, 1572 (2022).","journal-title":"Pharmaceutics"},{"key":"2284_CR21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2284_CR22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","volume":"20","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Mater. 20, 701\u2013710 (2021).","journal-title":"Nat. Mater."},{"key":"2284_CR23","doi-asserted-by":"crossref","first-page":"23814","DOI":"10.1021\/acsnano.3c07932","volume":"17","author":"X Yu","year":"2023","unstructured":"Yu, X. et al. Poly(ethyl ethylene phosphate): overcoming the \u2018polyethylene glycol dilemma\u2019 for cancer immunotherapy and mRNA vaccination. ACS Nano 17, 23814\u201323828 (2023).","journal-title":"ACS Nano"},{"key":"2284_CR24","doi-asserted-by":"crossref","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen, C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Deliv. Rev. 188, 114416 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2284_CR25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","volume":"34","author":"R Tenchov","year":"2023","unstructured":"Tenchov, R. et al. PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective. Bioconjug. Chem. 34, 941\u2013960 (2023).","journal-title":"Bioconjug. Chem."},{"key":"2284_CR26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A. et al. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e210925611 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2284_CR27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","volume":"157","author":"AO Elzoghby","year":"2012","unstructured":"Elzoghby, A. O. et al. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release 157, 168\u2013182 (2012).","journal-title":"J. Control. Release"},{"key":"2284_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2020.07.046","volume":"327","author":"M Abdallah","year":"2020","unstructured":"Abdallah, M. et al. Lymphatic targeting by albumin-hitchhiking: applications and optimisation. J. Control. Release 327, 117\u2013128 (2020).","journal-title":"J. Control. Release"},{"key":"2284_CR29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2022.11.034","volume":"353","author":"P Famta","year":"2022","unstructured":"Famta, P. et al. Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics. J. Control. Release 353, 166\u2013185 (2022).","journal-title":"J. Control. Release"},{"key":"2284_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12951-021-01232-5","volume":"20","author":"S Qi","year":"2022","unstructured":"Qi, S. et al. The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery. J. Nanobiotechnol. 20, 24 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"2284_CR31","volume":"8","author":"G Zhu","year":"2017","unstructured":"Zhu, G. et al. Albumin\/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy. Nat. Commun. 8, 1954 (2017).","journal-title":"Nat. Commun."},{"key":"2284_CR32","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/acs.bioconjchem.9b00760","volume":"30","author":"W Um","year":"2019","unstructured":"Um, W. et al. A comparative study on albumin-binding molecules for targeted tumor delivery through covalent and noncovalent approach. Bioconjug. Chem. 30, 3107\u20133118 (2019).","journal-title":"Bioconjug. Chem."},{"key":"2284_CR33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","volume":"507","author":"H Liu","year":"2014","unstructured":"Liu, H. et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507, 519\u2013522 (2014).","journal-title":"Nature"},{"key":"2284_CR34","doi-asserted-by":"crossref","first-page":"eabl3649","DOI":"10.1126\/scitranslmed.abl3649","volume":"14","author":"Y Song","year":"2022","unstructured":"Song, Y. et al. Albumin nanoparticle containing a PI3K\u03b3 inhibitor and paclitaxel in combination with \u03b1-PD1 induces tumor remission of breast cancer in mice. Sci. Transl. Med. 14, eabl3649 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2284_CR35","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","volume":"10","author":"T Lin","year":"2016","unstructured":"Lin, T. et al. Blood\u2013brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano 10, 9999\u201310012 (2016).","journal-title":"ACS Nano"},{"key":"2284_CR36","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/C5CS00158G","volume":"45","author":"Z Liu","year":"2016","unstructured":"Liu, Z. & Chen, X. Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy. Chem. Soc. Rev. 45, 1432\u20131456 (2016).","journal-title":"Chem. Soc. Rev."},{"key":"2284_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595, 572\u2013577 (2021).","journal-title":"Nature"},{"key":"2284_CR38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41565-021-01032-w","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat. Nanotechnol. 17, 206\u2013216 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"2284_CR39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2015.06.006","volume":"211","author":"M Bern","year":"2015","unstructured":"Bern, M. et al. The role of albumin receptors in regulation of albumin homeostasis: implications for drug delivery. J. Control. Release 211, 144\u2013162 (2015).","journal-title":"J. Control. Release"},{"key":"2284_CR40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1248\/cpb.c21-01024","volume":"70","author":"Y Ishima","year":"2022","unstructured":"Ishima, Y. et al. The new delivery strategy of albumin carrier utilizing the interaction with albumin receptors. Chem. Pharm. Bull. 70, 330\u2013333 (2022).","journal-title":"Chem. Pharm. Bull."},{"key":"2284_CR41","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1021\/acsnano.0c02767","volume":"14","author":"Y Wan","year":"2020","unstructured":"Wan, Y. et al. Stable organic photosensitizer nanoparticles with absorption peak beyond 800\u2009nanometers and high reactive oxygen species yield for multimodality phototheranostics. ACS Nano 14, 9917\u20139928 (2020).","journal-title":"ACS Nano"},{"key":"2284_CR42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566\u2013575 (2020).","journal-title":"Nat. Mater."},{"key":"2284_CR43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41563-023-01630-0","volume":"22","author":"LNM Nguyen","year":"2023","unstructured":"Nguyen, L. N. M. et al. The exit of nanoparticles from solid tumours. Nat. Mater. 22, 1261\u20131272 (2023).","journal-title":"Nat. Mater."},{"key":"2284_CR44","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2018.01643","volume":"9","author":"M Embgenbroich","year":"2018","unstructured":"Embgenbroich, M. & Burgdorf, S. Current concepts of antigen cross-presentation. Front. Immunol. 9, 1643 (2018).","journal-title":"Front. Immunol."},{"key":"2284_CR45","first-page":"274","volume":"12","author":"F O\u011fuz","year":"2022","unstructured":"O\u011fuz, F. & Atmaca, H. mRNA as a therapeutics: understanding mRNA vaccines. Adv. Pharm. Bull. 12, 274\u2013282 (2022).","journal-title":"Adv. Pharm. Bull."},{"key":"2284_CR46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","volume":"17","author":"KA Szymonowicz","year":"2020","unstructured":"Szymonowicz, K. A. & Chen, J. Biological and clinical aspects of HPV-related cancers. Cancer Biol. Med. 17, 864 (2020).","journal-title":"Cancer Biol. Med."},{"key":"2284_CR47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2017.08.001","volume":"170","author":"L Mirabello","year":"2017","unstructured":"Mirabello, L. et al. HPV16 E7 genetic conservation is critical to carcinogenesis. Cell 170, 1164\u20131174 (2017).","journal-title":"Cell"},{"key":"2284_CR48","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6750-12-77","volume":"12","author":"E Feshchenko","year":"2012","unstructured":"Feshchenko, E. et al. Pandemic influenza vaccine: characterization of A\/California\/07\/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol. 12, 77 (2012).","journal-title":"BMC Biotechnol."},{"key":"2284_CR49","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","volume":"177","author":"JG Cyster","year":"2019","unstructured":"Cyster, J. G. & Allen, C. D. C. B cell responses: cell interaction dynamics and decisions. Cell 177, 524\u2013540 (2019).","journal-title":"Cell"},{"key":"2284_CR50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva, N. S. & Klein, U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 15, 137\u2013148 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"2284_CR51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cmet.2022.12.014","volume":"35","author":"MJ Mittenb\u00fchler","year":"2023","unstructured":"Mittenb\u00fchler, M. J. et al. Isolation of extracellular fluids reveals novel secreted bioactive proteins from muscle and fat tissues. Cell Metab. 35, 535\u2013549 (2023).","journal-title":"Cell Metab."},{"key":"2284_CR52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2014.10.010","volume":"159","author":"N Renier","year":"2014","unstructured":"Renier, N. et al. iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159, 896\u2013910 (2014).","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1038\/s41563-025-02343-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000}}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02284-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:52Z","timestamp":1761847732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-025-02284-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1038\/s41563-025-02284-w","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41563-025-02343-2","URL":"https:\/\/doi.org\/10.1038\/s41563-025-02343-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}